Amgen Inc (NASDAQ:AMGN)
| 229.51 Delayed Data As of May 29 |  +5.57 / +2.49%Today’s Change | 166.68 Today|||52-Week Range 244.99 | -4.80% Year-to-Date |
Latest AMGN News | Press Releases
| Nasdaq Today: Why Alexion and Workday Stock Are Soaring May 28 / MotleyFool.com - Paid Partner Content | Is Arrowhead Pharmaceuticals a Buy? May 24 / MotleyFool.com - Paid Partner Content |
| Is Coherus BioSciences a Buy? May 26 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 224.13 |
| Today’s open | 225.00 |
| Day’s range | 222.06 - 230.57 |
| Volume | 4,251,215 |
| Average volume (3 months) | 3,243,167 |
| Market cap | $135.1B |
Data as of 4:00pm ET, 05/29/2020
Growth & Valuation
| Earnings growth (last year) | +2.07% |
| Earnings growth (this year) | +4.85% |
| Earnings growth (next 5 years) | +7.07% |
| Revenue growth (last year) | -2.13% |
| P/E ratio | 18.0 |
| Price/Sales | 6.31 |
| Price/Book | 14.04 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | +2.51 | +3.33% |
| ILMNIllumina Inc | -9.96 | -2.67% |
| BIIBBiogen | +6.59 | +2.19% |
| MRNAModerna Inc | +5.96 | +10.73% |
Data as of 7:39pm ET, 05/29/2020
Financials
| Next reporting date | July 22, 2020 |
| EPS forecast (this quarter) | $3.80 |
| Annual revenue (last year) | $23.3B |
| Annual profit (last year) | $7.8B |
| Net profit margin | 33.71% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Thousand Oaks, California |
Forecasts
